Антифосфолипидный синдром - часть 49

201

151. Espinosa G, Cervera R, Font J, Asherson

RA. The lung in the antiphospholipid syndrome
Ann Rheum Dis. 2002; 61: 195—198.

152. Asherson RA, Cervera R. Review: anti

phospholipid antibodies and the lung. J Rheu
matology 1995; 22: 62—66.

153. Luchi ME, Asherson RA, Lahita RG.

Primary idiopathic pulmonary hypertension com
plicated by pulmonary arterial thrombosis:
Association with antiphospholipid antibodies.
Arthritis Rheum 1992; 35: 700—705.

154. Asherson RA, Oakley CN. Pulmonary

hypertension and systemic lupus erythematosus. J
Rheumatol 1986; 13: 1—5.

155. Ghosh S, Walters HD, Joist JH, Osborn

TG, Moore TL. Adult respiratory distress syn
drome associated with antiphospholipid anti
body syndrome. J Rheumatol 1993; 20: 1406—
1408.

156. Howe HS, Boey ML, Fong KY, Feng PH.

Pulmonary haemorrhage, pulmonary infarction
and the lupus anticoagulant. Ann Rheum Dis
1988; 47: 869—872.

157. Maggiorine M, Knoblauch A, Schneider J,

et al. Diffuse microvascular pulmonary thrombo
sis in primary antiphospholipid syndrome. Eur
Resp J 1997; 10: 727—730.

158. Gertner E, Lie JT. Pulmonary capillaritis,

alveolar haemorrhage and recurrent microvascu
lar thrombosis in primary antiphospholipid syn
drome. J Rheumatol 1993; 20: 1224—1228.

159. Savin H, Huberman M, Koh E, et al.

Fibrosing alveolitis associated with primary
antiphospholipid syndrome. Br J Rheumatology
1994; 33: 977—980.

160. Brucato A, Baudo F, Barberis M. et al.

Pulmonary hypertension secondary to thrombosis
of the pulmonary vessels in a patient with the pri
mary antiphospholipid syndrome. J Rheumatol
1994; 2: 942—944.

161. Turijansku AA, Finkielman JD, Vazquez

Blanco. Isolated tricuspidal valve disease in
antiphospholipid syndrome. Lupus 1998; 8: 474—
476.

162. Moser KM, Auger WR, Fedullo PF.

Chronic majorvessel thromboembolic pulmonary
hypertension. Circulation 1990; 81: 1735—1743.

163. Jamieson SW, Auger WR, Fedullo PF, et

al. Experience and results with 150 pulmonary

thromboendarterectomy operations over a 29
month period. J Thorac Cardiovascular Surg
1993; 106: 116—127.

164. Sandaval J, Amigo MC, Barragan R, et al.

Primary antiphospholipid syndrome presenting as
chronic thromboembolic hypertension. Treatment
with Thromoendarterctomy. J Rheumatol 1996;
23: 772—775.

165. Crausman RS, Achenbach GA, Pluss WT,

et al. Pulmonary capillaritis and alveolar haem
orrhage associated with the antiphospholipid syn
drome. J Rheumatol 1995; 22: 554—556.

166. Schwab EP, Schumacher HR, Freundlich

B, Callegari PE. Pulmonary alveolar haemor
rhage in systemic lupus erythematosus. Semin
Arthritis Rheum 1993; 23: 8—15.

167. Hillerdal G, Hagg A, Licke G, Wegenius

G, Scheibenflug L. Intraalveolar haemorrhage in
the anticardiolipin antibody syndrome. Scand J
Rheumatol 1991; 20: 58—62.

168. Kelion AD, Cockroft JR, Ritter JM. Anti

phospholipid syndrome in a patient with rapidly
progressive fibrosing alveolitis. Postgrad Med J
1994; 71: 233—235.

169. Branch DW, Kochenour NP, Rote NS, et

al. New postpartum syndrome associated with
antiphospholipid antibodies. Obstet Gynecol
1987; 69: 460—468.

170. Kerr JE, Poe R, Kramer Z. Antiphos

pholipid antibody syndrome presenting as a
refractory noninflammatory pulmonary vascu
lopathy. Chest 1997; 112: 1707—1710.

171. Asherson RA, Hughes GRV. Hypoadre

nalism, Addison's disease and antiphospholipid
antibodies. J Rheumatol 1991; 18: 1—3.

172. Asherson RA. Hypoadrenalism and the

antiphospholipid antibodies. A new cause of idio
pathic "Addison's disease". In: Bhatt, James,
Besser, Botazzo, Keen (eds): Advances in Thomas
Addison's diseases. Vol. 1. J Endocrinol Ltd.
Bristol. 1994; 87—101.

173. Arnason JA, Graziano FM. Adrenal insuffi

ciency in the antiphospholipid antibody syndrome.
Semin Arthritis Rheum 1995; 25: 109—116.

174. Pelkonen P, Simell O, Rasi V, et al.

Venous thrombosis associated with the lupus anti
coagulant. Ann Intern Med 1980; 92: 156—159.

175. Grottolo A, Ferrari V, Mariarosa M, et al.

Primary adrenal insufficiency, circulating Lupus

ГЛАВА 7. Клинические проявления антифосфолипидного синдрома

Насонов Е.Л. Антифосфолипидный синдром

202

Anticoagulant and anticardiolipin antibodies in a
patient with multiple abortions and recurrent
thrombotic episodes. Haematologia 1988; 73:
517—519.

176. Asherson RA, Hughes GRV. Recurrent deep

vein thrombosis in Addison's disease in "primary"
antiphospholipid syndrome. J Rheumatol 1989; 16:
378—380. Carette S, Jobin F. Acute adrenal insuf
ficiency as a manifestation of the anticardiolipin
syndrome. Ann Rheum Dis 1989; 48: 430—431.

177. Rao R, Vagnucci A, Amico J. Bilateral mas

sive adrenal haemorrhage: Early recognition and
treatment. Ann Intern Med 1989; 110: 227—235.

178. Marie I, Levesque H, Heron F, Kailleux

N, Borg JY, Courtois H. Acute adrenal failure
secondary to bilateral infarction of the adrenal
glands as the first manifestation of primary
antiphospholipid antibody syndrome. Ann Rheum
Dis 1997; 567—568.

179. Argento A, Di Benedetto RJ. ARDS and

adrenal insufficiency associated with the
antiphospholipid antibody syndrome. Chest 1998;
113: 1136—1138.

180. Guibal F, Rybojad M, Cordoliani F, et al.

Melanoderma revealing primary antiphospholipid
syndrome. Dermatol 1996; 192: 75—77.

181. Provenzale JM, Ortel TL, Nelson RC.

Adrenal haemorrhages in patients with primary
antiphospholipid syndrome: Imaging findings. Am
J Roentgenol 1995; 165: 361—364.

182. Oelkers W. Adrenal insufficiency IV. N

Engl J Med 1996; 335: 1206—1212.

183. Pomeroy C, Knodell RG, Swain WR,

Arneson P, Mahowald ML. BuddChiari syn
drome in a patient with the lupus anticoagulant.
Gastroenterology 1984; 86: 158—161.

184. Shimizu S, Miyata M, Kamiike W, et al.

BuddChiari syndrome combined with antiphos
pholipid syndrome: Case report and literature
review. Vasc Surg 1993; 501—509.

185. Farrant JM, Judge M, Thompson RDH.

Thrombotic cutaneous nodules and hepatic vein
thrombosis in the anticardiolipin syndrome. Clin
Exp Dermatol 1989; 14: 306—308.

186. Ouwendijk RJT, Koster JC, Wilson JHP,

et al. BuddChiari syndrome in a young patient
with anticardiolipin antibodies: Need for pro
longed anticoagulant treatment. Gut 1994; 35:
1004—1006.

187. MackworthYoung CG, Gharavi AE, Boey

ML, Hughes GRV. Portal and pulmonary hyper
tension in a case of systemic lupus erythematosus:
Possible relationship with a clotting abnormality.
Eur J Rheum Inflam 1984; 7: 71—74.

188. Ordi J, Vargas V, Vilardell M, et al. Lupus

anticoagulant and portal hypertension. Am J Med
1988; 84: 566—568.

189. De Clerck L, Michielsen PP, Ramael MR,

et al. Portal and pulmonary vessel thrombosis
associated with systemic lupus erythematosus and
anticardiolipin antibodies. J Rheumatol 1991; 18:
1919—1921.

190. Takahaski C, Kumagai S, Tsubata R, et

al. Portal hypertension associated with anticardi
olipin antibodies in case of systemic lupus
eErythematosus. Lupus 1995; 4: 232—235.

191. Mantz FA, Craige E. Portal axis thrombo

sis with spontaneous portacaval shunt and result
ant cor pulmonale. Arch Pathol 1951; 52: 91—97.

192. Nakamura H, Uehara H, Okada T, et al.

Occlusion of small hepatic veins associated with
systemic lupus erythematosus with the lupus anti
coagulant. Hepatogastroenterol 1989; 36: 393—
397.

193. Morio S, Oh H, Hirasawa A, et al. Hepatic

venoocclusive disease in a patient with lupus
anticoagulant after allogeneic bone marrow
transplantation. Bone Marrow Transplant 1991;
8: 147—149.

194. Morle RM, RamosCasals M, Garcia

Carrasco M, et al. Nodular regenerative hyper
plasia of the liver and antiphospholipid antibod
ies: report of two cases and review of the literature.
Lupus 1999; 8: 160—163.

195. Rio B, Andreu G, Nicod A, et al.

Thrombocytopenia in venoocclusive disease after
bone marrow transplantation or chemotherapy.
Blood 1986; 67: 1773—1776.

196. Perez—Ruiz F, OrteMartinez FJ, Zea

Mendoza AC, Ruiz del Arbol L, Moreno
Caparras A. Nodular regenerative hyperplasia of
the liver in rheumatic diseases: report of seven
cases and review of the literature. Semin Arthritis
Rheum 1991; 21: 47—54.

197. Mor T, Beigel Y, Inbal A, Goren M,

Wysenbeek A G. Hepatic infarction in a patient
with the lupus anticoagulant. Arthritis Rheum
1989; 32: 491—495.

203

198. Kinoshita K. Hepatic infarction during

pregnancy complicated by antiphospholipid syn
drome. Amer J Obstet Gynecol 1993; 169: 199—
202.

199. Young N, Wong KP. Antibody to cardi

olipin causing hepatic infarction in a postpartum
patient with systemic lupus erythematosus. Aus
Radiol 1991; 35: 83—85.

200. Saeki R, Kaneko S, Terasaki S, et al.

Mixed types of chronic active hepatitis and pri
mary biliary cirrhosis associated with the
antiphospholipid antibody syndrome.
Hepatogastroenterol 1993; 40: 499—501.

201. Beales ILP. An acquired pseudoBernard

Soulier syndrome occurring with autoimmune
chronic active hepatitis and anticardiolipin anti
body. Postgrad Med J 1994; 70: 305—308.

202. Kesler A, Pomeranz IS, Huberman H,

Movis B, Kott E. Cerebral venous thrombosis and
chronic active hepatitis as part of the antiphos
pholipid antibody syndrome. Postgrad Med J
1996; 72: 690—692.

203. Cappell M. Oesophageal necrosis and per

foration associated with the anticardiolipin anti
body syndrome. Am J Gastroenterol 1994; 89:
1241—1245.

204. Kalman DR, Khan A, Ramain PL,

Nompleggi DJ. Giant gastric ulceration associat
ed with antiphospholipid antibody syndrome. Am
J Gastroenterol 1996; 91: 1244—1247.

205. Asherson RA, Morgan S, Harris EN, et al.

Arterial occlusion causing large bowel infarction:
A reflection of clotting diathesis in SLE. Clin
Rheumatol 1986; 5: 102—106.

206. Asherson RA, MackworthYoung C,

Harris EN, et al. Multiple venous and arterial
thromboses associated with the lupus anticoagu
lant and antibodies to cardiolipin in the absence
of SLE. Rheumatol Int 1985; 5: 90—93.

207. SanchezGuerrero J, Reyes E, Alarcon

Segovia D. Primary antiphospholipid syndrome
as a cause of intestinal infarction. J Rheumatol
1992 19: 623—625.

208. Hamilton ME. Superior mesenteric artery

thrombosis associated with antiphospholipid syn
drome. West J Med 1991; 155: 174—176.

209. Blanc P, Barki J, Fabre JM, Larrey D,

Domergue J, Michel M, LavabarBertrand T.
Superior mesenteric vein thrombosis associated

with anticardiolipin antibody without autoim
mune disease. J Lab Invest 1995; 72: 137.

210. England RJA, Woodcock B, Zeiderman

MR. Superior mesenteric artery thrombosis in a
patient with the antiphospholipid syndrome. Eur J
Vasc Endovasc Surg 1995; 10: 372—373.

211. Vahl AC, Gans ROB, Mackaay AJC, Van

Der Waal C, Mauwerda JA. Superior mesenteric
artery occlusion and peripheral emboli caused by
an aortic ulcer in a young patient with antiphos
pholipid syndrome. Surg 1997; 121: 588—590.

212. Cappell MS, Mikhail N, Gujral N. Gastro

intestinal haemorrhage and intestinal ischaemia
associated with anticardiolipin antibodies. Dig
Dis Sciences 1994; 39: 1359—1364.

213. Date K, Shirai Y, Hatakeyama K.

Antiphospholipid antibody syndrome presenting
as acute acalculous cholecystitis. Am J
Gastroenterol 1997: 2127—2128.

214. Arnold MH, Schreiber L. Splenic and

renal infarction in systemic lupus eythematosus:
Association with anticardiolipin antibodies. Clin
Rheumatol 1988; 7: 406—410.

215. Pettersson T, Julkunen H. Asplenia in a

patient with systemic lupus erythematosus and
antiphospholipid antibodies. J Rheumatol 1992;
19: 115.

216. Frances C, Piette JC. Cutaneous man

ifestations of Hughes syndrome in the contex of
lupus erythematosus. Lupus 1997; 6: 139—
144.

217. Kleiner RC, Najarian IV, Schatten S, et

al. Vasoocclusive retinopathy associated with
antiphospholipid antibodies (lupus anticoagu
lant retinopathy). Ophthalmology 1989; 96:
896—904.

218. Frances C, Tribout B, Boisnic S, et al.

Cutaneous necrosis associated with the lupus
anticoagulant. Dermatologica 1989; 178: 194—
201.

219. Dessein PH, Lamparelli RD, Phillips SA,

Rubenchik IA, Zwi S. Severe immune thrombocy
topenia and the development of skin infarctions in
a patient with an overlap syndrome. J Rheumatol
1989; 16: 1494—1496.

220. Dodd HJ, Sarkany I, O'Shaughnessy D.

Widespread cutaneous necrosis associated with
the lupus anticoagulant. Clin Exp Dermatol 1985;
10: 581—586.

ГЛАВА 7. Клинические проявления антифосфолипидного синдрома

Насонов Е.Л. Антифосфолипидный синдром

204

221. Aronoff DM, Callen JP. Necrosing livedo

reticularis in a patient with recurrent pulmonary
haemorrhage. J Am Acad Dermatol 1997; 37:
300—302.

222. Soweid M, Hajjar RR, HewanLow KO,

Gonzalez EB. Skin necrosis indicating antiphos
pholipid syndrome in a patient with AIDS. South
Med J 1995; 88: 786—788.

223. Del Castillo LF, Soria C, Schoendorff C,

et al. Widespread cutaneous necrosis and
antiphospholipid antibodies: Two episodes relat
ed to surgical manipulation and urinary tract
infection. J Am Acad Dermatol 1997; 36: 872—
875.

224. Amster MS, Conway J, Zeid M, et al.

Cutaneous necrosis resulting in protein S defi
ciency and increased antiphospholipid antibody
in a patient with systemic lupus erythematosus. J
Am Acad Dermatol 1993; 29: 853—857.

225. Wolf P, Soyer P, AuerGrumbach P, et al.

Widespread cutaneous necrosis in a patient with
rheumatoid arthritis associated with anticardi
olipin antibodies. Arch Dermatol 1991; 127:
1739—1740.

226. Hill VA, Whittaker SJ, Hunt BJ, et al.

Cutaneous necrosis associated with the antiphos
pholipid syndrome and mycosis fungoides. Br J
Dermatol 1994; 130: 92—96.

227. Doff HJ, Sarkany I, O'Shaughnessy D.

Widespread cutaneous necrosis associated with
the lupus anticoagulant. Clin Exp Dermatol 1985;
10: 581—586.

228. Wattiaux HJ, Herve R, Robert A,

Cabane J, Housset B, Imbert JC. Coumarin
induced skin necrosis associated with acquired
protein S deficiency and antiphospholipid anti
body syndrome. Arthritis Rheum 1994; 37:
1096—1100.

229. Asherson RA, Jacobelli S, Rosenberg H, et

al. Skin nodules and macules resembling vasculi
tis in the antiphospholipid syndrome. Clin Exp
Dermatol 1992; 17: 166—169.

230. Renfro L, Franks AG, Grudberg M,

Kamino H. Painful nodules in a young female —
Antiphospholipid syndrome. (Technical Note).
Arch Dermat 1992; 128: 847.

231. Asherson RA. Subungual splinter haemor

rhages: a new sign of the antiphospholipid coagu
lopathy? Ann Rheum Dis 1990; 49: 268.

232. Frances C, Piette J, Saada V, et. al. Mul

tiple subungual splinter haemorrhages in the
antiphospholipid syndrome. A report of 5 cases
and review of the literature. Lupus 1994; 30:
123—128.

233. Kleiner RC, Najarian IV, Schatten S, et

al. Vasoocclusive retinopathy associated with
antiphospholipid antibodies (lupus anticoagulant
retinopathy). Ophthalmology 1989; 96: 896—
904.

234. Digre KB, Durcan FJ, Branch DW,

Jacobson DM, Varner MW, Baringer JR.
Amaurosis fugax associated with antiphospholipid
antibodies. Ann Neurol 1989; 25: 228—232.

235. Carbone J, SanchezRamon S, Cobo

Soriano R, et al. Antiphospholipid antibodies: A
risk factor for occlusive retinal vascular disorders.
Comparison with ocular inflammatory diseases. J
Rheumatol 2001; 28: 2437.

236. Liote F, Meyer O, Osteoarticular manifes

tations in the antiphospholipid syndrome. In:
Asherson R A, Cervera R, Piette JC, Shoenfeld Y
(Eds). The antiphospholipid syndrome. CRC
Press. Boca Raton 1996; 195—200.

237. Klippel TM, Stevens MB, Zizic TM, Hun

gerford DS. Ischemic necrosis of bone in systemic
lupus erythematosus. Medicine (Baltimore) 1976;
55: 251—257.

238. Glueck CJ, Freiberg R, Glueck HE, et al.

Hypofibrinolisis: a common, major cause of
osteonecrosis. Am J Mematol 1994; 45: 156—
166.

239. Asherson RA, Jungers P, Liot F, et al.

Ischaemic necrosis of bone associated with the
"lupus anticoagulant" and antibodies to cardi
olipin. Proceedings of the XVIth International
Congress of Rheumatology. Sydney, Australia.
1983; 373.

240. Asherson RA, Liot F, Page B, et al. Avas

cular necrosis of bone and antiphospholipid anti
bodies in systemic lupus erythematosus. J
Rheumatol 1993; 20: 284—288.

241. Seleznick MJ, Silveira LH, Espinoza LR.

Avascular necrosis associated with anticardi
olipin antibodies. J Rheumatol 1991; 18: 1416—
1417.

242. Alijotas J, Argem M, Barquinero J.

Kienbock's disease and antiphospholipid antibod
ies. Clin Exp Rheumatol 1990; 8 297—298.